Save the date—there's an upcoming virtual meeting for people living with rare diseases, like scleroderma, to discuss the development of therapeutics. 💻
On December 14, 2023 from 12:00 - 5:00 PM ET, the FDA in collaboration with the Duke-Robert J. Margolis, MD Center for Health Policy will be hosting a virtual public meeting. The purpose of this meeting is "to discuss opportunities for engaging the rare disease patient community. This engagement can help inform the development of therapeutics to treat rare diseases and conditions."
For more information about discussion topics, speaker bios, and how to register, visit: https://bit.ly/3ReQlp5
#scleroderma #raredisease #virtualmeeting #sayscleroderma #srfcure
Great news! felzartamab looks to be very promising across a number of indications.